ProfileGDS4718 / 223372_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 37% 31% 43% 42% 26% 31% 40% 33% 33% 40% 30% 35% 37% 28% 36% 33% 33% 35% 40% 36% 27% 38% 36% 33% 30% 35% 30% 36% 40% 40% 31% 39% 33% 24% 33% 37% 36% 37% 28% 34% 42% 29% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8107536
GSM549102patient 115, normal, homogenized [OPG study]4.8571237
GSM549104patient 119, normal, homogenized [OPG study]4.5531831
GSM549108patient 138, normal, homogenized [OPG study]5.1877143
GSM549119patient 077, normal, homogenized [OPG study]5.1216342
GSM549133patient 032, cancer, homogenized [OPG study]4.3286226
GSM549139patient 042, cancer, homogenized [OPG study]4.5835631
GSM549099patient 107, normal, homogenized [OPG study]5.0187840
GSM549109patient 139, normal, homogenized [OPG study]4.707933
GSM549110patient 046, normal, homogenized [OPG study]4.6710833
GSM549114patient 063, normal, homogenized [OPG study]4.9625740
GSM549122patient 082, normal, homogenized [OPG study]4.5336430
GSM549134patient 033, cancer, homogenized [OPG study]4.7560635
GSM549136patient 036, cancer, homogenized [OPG study]4.7668537
GSM549140patient 044, cancer, homogenized [OPG study]4.4124628
GSM549111patient 047, normal, homogenized [OPG study]4.766436
GSM549113patient 057, normal, homogenized [OPG study]4.613133
GSM549132patient 031, cancer, homogenized [OPG study]4.6717733
GSM549137patient 038, cancer, homogenized [OPG study]4.7415835
GSM549142patient 047, cancer, homogenized [OPG study]5.1396440
GSM549100patient 110, normal, homogenized [OPG study]4.8213936
GSM549107patient 135, normal, homogenized [OPG study]4.3895827
GSM549115patient 068, normal, homogenized [OPG study]4.8428538
GSM549116patient 072, normal, homogenized [OPG study]4.7993136
GSM549120patient 078, normal, homogenized [OPG study]4.6607633
GSM549131patient 030, cancer, homogenized [OPG study]4.4938130
GSM549118patient 074, normal, homogenized [OPG study]4.7728335
GSM549129patient 027, cancer, homogenized [OPG study]4.58230
GSM549123patient 088, normal, homogenized [OPG study]4.7976436
GSM549124patient 006, cancer, homogenized [OPG study]5.0186240
GSM549126patient 015, cancer, homogenized [OPG study]4.9744440
GSM549128patient 025, cancer, homogenized [OPG study]4.5449631
GSM549103patient 117, normal, homogenized [OPG study]4.9868239
GSM549117patient 073, normal, homogenized [OPG study]4.6385633
GSM549138patient 041, cancer, homogenized [OPG study]4.2824624
GSM549141patient 045, cancer, homogenized [OPG study]4.6040833
GSM549130patient 028, cancer, homogenized [OPG study]4.8479837
GSM549101patient 111, normal, homogenized [OPG study]4.812536
GSM549105patient 128, normal, homogenized [OPG study]4.8644137
GSM549106patient 134, normal, homogenized [OPG study]4.4162728
GSM549112patient 048, normal, homogenized [OPG study]4.7010734
GSM549125patient 011, cancer, homogenized [OPG study]5.0843742
GSM549127patient 024, cancer, homogenized [OPG study]4.4623329
GSM549135patient 035, cancer, homogenized [OPG study]4.4761230